CombinatoRx gets leadership award

CombinatoRx Inc. announced today that it has received the Marjorie Guthrie Leadership Award from the Huntington's Disease Society of America.

The Guthrie family created the Woody and Marjorie Guthrie Research Fund to pay tribute to legendary folk singer Woody Guthrie, who died from complications associated with Huntington's disease.

CombinatoRx is a Cambridge company focused on synergistic combination pharmaceuticals.

The quest to relieve the symptoms and causes of Huntington's disease requires "new approaches, new methodologies, and new ways of thinking," said C. Walt Johnston, the society's chairman, in a statement, and CombinatoRx "exemplifies these qualities with its unique approach to drug discovery as well as continued patient support efforts."
(By Chris Reidy, Globe staff)